Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

Схожие документы

• Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
  по: Hoy, Sheridan M.
  Опубликовано: (2018)
• Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
  по: Fingeret, Murray, et al.
  Опубликовано: (2019)
• Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
  по: Addis, Victoria M, et al.
  Опубликовано: (2018)
• Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
  по: Weinreb, Robert N., et al.
  Опубликовано: (2018)
• Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
  по: Kawase, Kazuhide, et al.
  Опубликовано: (2016)